Brentuximab Vedotin or Crizotinib and Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II-IV Anaplastic Large Cell Lymphoma
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Canadian Cancer Trials Group
Goethe University
Gustave Roussy, Cancer Campus, Grand Paris
Canadian Cancer Trials Group
Fred Hutchinson Cancer Center
University of Washington